HEADER TRANSFERASE/TRANSFERASE INHIBITOR 23-DEC-13 4O6W
TITLE PEPTIDE-BASED INHIBITORS OF PLK1 POLO-BOX DOMAIN
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PLK1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: POLO BOX DOMAIN (UNP RESIDUES 371-603);
COMPND 5 SYNONYM: POLO-LIKE KINASE 1, PLK-1, SERINE/THREONINE-PROTEIN KINASE
COMPND 6 13, STPK13;
COMPND 7 EC: 2.7.11.21;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: PEPTIDE-BASED INHIBITOR;
COMPND 11 CHAIN: C;
COMPND 12 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: PLK1, PLK;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 SYNTHETIC: YES
KEYWDS POLO BOX DOMAIN, PHOSPHO-PEPTIDE BINDING, PHOSPHOPEPTIDE,
KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR W.-J.QIAN,J.-E.PARK,D.C.LIM,S.-Y.PARK,K.-W.LEE,M.B.YAFFE,K.S.LEE,
AUTHOR 2 T.R.BURKE
REVDAT 1 03-DEC-14 4O6W 0
SPRSDE 03-DEC-14 4O6W 4MLU
JRNL AUTH W.J.QIAN,J.E.PARK,D.LIM,C.C.LAI,J.A.KELLEY,S.Y.PARK,K.W.LEE,
JRNL AUTH 2 M.B.YAFFE,K.S.LEE,T.R.BURKE
JRNL TITL MONO-ANIONIC PHOSPHOPEPTIDES PRODUCED BY UNEXPECTED
JRNL TITL 2 HISTIDINE ALKYLATION EXHIBIT HIGH PLK1 POLO-BOX
JRNL TITL 3 DOMAIN-BINDING AFFINITIES AND ENHANCED ANTIPROLIFERATIVE
JRNL TITL 4 EFFECTS IN HELA CELLS.
JRNL REF BIOPOLYMERS V. 102 444 2014
JRNL REFN ISSN 0006-3525
JRNL PMID 25283071
JRNL DOI 10.1002/BIP.22569
REMARK 2
REMARK 2 RESOLUTION. 1.45 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-
REMARK 3 : KUNSTLEVE,LI-WEI HUNG,ROBERT IMMORMINO,
REMARK 3 : TOM IOERGER,AIRLIE MCCOY,ERIK MCKEE,NIGEL
REMARK 3 : MORIARTY,REETAL PAI,RANDY READ,JANE
REMARK 3 : RICHARDSON,DAVID RICHARDSON,TOD ROMO,JIM
REMARK 3 : SACCHETTINI,NICHOLAS SAUTER,JACOB SMITH,
REMARK 3 : LAURENT STORONI,TOM TERWILLIGER,PETER
REMARK 3 : ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.86
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1
REMARK 3 NUMBER OF REFLECTIONS : 35356
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.185
REMARK 3 R VALUE (WORKING SET) : 0.184
REMARK 3 FREE R VALUE : 0.215
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.660
REMARK 3 FREE R VALUE TEST SET COUNT : 2000
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 14.8607 - 3.4754 0.91 2328 139 0.1623 0.1746
REMARK 3 2 3.4754 - 2.7643 0.98 2448 147 0.1758 0.2353
REMARK 3 3 2.7643 - 2.4166 0.99 2470 149 0.1955 0.2106
REMARK 3 4 2.4166 - 2.1964 0.99 2459 147 0.1822 0.2000
REMARK 3 5 2.1964 - 2.0394 0.99 2457 147 0.1812 0.2237
REMARK 3 6 2.0394 - 1.9194 0.98 2418 146 0.1879 0.2035
REMARK 3 7 1.9194 - 1.8235 0.98 2429 145 0.1906 0.2170
REMARK 3 8 1.8235 - 1.7442 0.97 2387 143 0.1870 0.2399
REMARK 3 9 1.7442 - 1.6772 0.97 2375 143 0.1949 0.2086
REMARK 3 10 1.6772 - 1.6194 0.96 2369 141 0.1995 0.2612
REMARK 3 11 1.6194 - 1.5688 0.95 2347 141 0.1966 0.2639
REMARK 3 12 1.5688 - 1.5240 0.95 2334 140 0.2141 0.2351
REMARK 3 13 1.5240 - 1.4839 0.94 2324 139 0.2652 0.3529
REMARK 3 14 1.4839 - 1.4477 0.90 2211 133 0.3563 0.3873
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.540
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.003 1968
REMARK 3 ANGLE : 0.844 2658
REMARK 3 CHIRALITY : 0.063 293
REMARK 3 PLANARITY : 0.003 329
REMARK 3 DIHEDRAL : 11.793 752
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4O6W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JAN-14.
REMARK 100 THE RCSB ID CODE IS RCSB084117.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 20-JUN-12
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : OSMIC MIRRORS
REMARK 200 OPTICS : OSMIC MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35356
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450
REMARK 200 RESOLUTION RANGE LOW (A) : 15.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50
REMARK 200 COMPLETENESS FOR SHELL (%) : 94.2
REMARK 200 DATA REDUNDANCY IN SHELL : 2.70
REMARK 200 R MERGE FOR SHELL (I) : 0.22500
REMARK 200 R SYM FOR SHELL (I) : 0.22500
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 33.57
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 13% (W/V) PEG 3350, 0.1 M HEPES PH 7.5
REMARK 280 AND 100 MM NACL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.63750
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 1610 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 10990 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400
REMARK 400 COMPOUND
REMARK 400
REMARK 400 THE PHOSPHOTHREONINE ESTER-CONTAINING PEPTIDE IS POLYPEPTIDE, A
REMARK 400 MEMBER OF ENZYME INHIBITOR CLASS.
REMARK 400
REMARK 400 GROUP: 1
REMARK 400 NAME: PHOSPHOTHREONINE ESTER-CONTAINING PEPTIDE
REMARK 400 CHAIN: C
REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER
REMARK 400 DESCRIPTION: NULL
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY A 367
REMARK 465 ALA A 368
REMARK 465 HIS A 369
REMARK 465 MET A 370
REMARK 465 ASP A 371
REMARK 465 CYS A 372
REMARK 465 GLY A 502
REMARK 465 ASP A 503
REMARK 465 GLU A 504
REMARK 465 LEU A 505
REMARK 465 ALA A 506
REMARK 465 SER A 595
REMARK 465 ALA A 596
REMARK 465 SER A 597
REMARK 465 ASN A 598
REMARK 465 ARG A 599
REMARK 465 LEU A 600
REMARK 465 LYS A 601
REMARK 465 ALA A 602
REMARK 465 SER A 603
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 2SO C 4 C32 C33 C34 O3 O4
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH A 889 O HOH C 113 2.15
REMARK 500 OD1 ASP A 457 O HOH A 883 2.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ARG A 392 -130.00 -124.22
REMARK 500 ARG A 396 50.82 -119.74
REMARK 500 LYS A 420 -45.14 -132.84
REMARK 500 ASP A 449 -37.29 -140.40
REMARK 500 LEU A 463 -168.60 -161.46
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CHIRAL CENTERS
REMARK 500
REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL
REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY
REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR
REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE
REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16)
REMARK 500
REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS
REMARK 500 HIS A 489 24.9 L L OUTSIDE RANGE
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH A 869 DISTANCE = 5.20 ANGSTROMS
DBREF 4O6W A 371 603 UNP P53350 PLK1_HUMAN 371 603
DBREF 4O6W C 1 7 PDB 4O6W 4O6W 1 7
SEQADV 4O6W GLY A 367 UNP P53350 EXPRESSION TAG
SEQADV 4O6W ALA A 368 UNP P53350 EXPRESSION TAG
SEQADV 4O6W HIS A 369 UNP P53350 EXPRESSION TAG
SEQADV 4O6W MET A 370 UNP P53350 EXPRESSION TAG
SEQRES 1 A 237 GLY ALA HIS MET ASP CYS HIS LEU SER ASP MET LEU GLN
SEQRES 2 A 237 GLN LEU HIS SER VAL ASN ALA SER LYS PRO SER GLU ARG
SEQRES 3 A 237 GLY LEU VAL ARG GLN GLU GLU ALA GLU ASP PRO ALA CYS
SEQRES 4 A 237 ILE PRO ILE PHE TRP VAL SER LYS TRP VAL ASP TYR SER
SEQRES 5 A 237 ASP LYS TYR GLY LEU GLY TYR GLN LEU CYS ASP ASN SER
SEQRES 6 A 237 VAL GLY VAL LEU PHE ASN ASP SER THR ARG LEU ILE LEU
SEQRES 7 A 237 TYR ASN ASP GLY ASP SER LEU GLN TYR ILE GLU ARG ASP
SEQRES 8 A 237 GLY THR GLU SER TYR LEU THR VAL SER SER HIS PRO ASN
SEQRES 9 A 237 SER LEU MET LYS LYS ILE THR LEU LEU LYS TYR PHE ARG
SEQRES 10 A 237 ASN TYR MET SER GLU HIS LEU LEU LYS ALA GLY ALA ASN
SEQRES 11 A 237 ILE THR PRO ARG GLU GLY ASP GLU LEU ALA ARG LEU PRO
SEQRES 12 A 237 TYR LEU ARG THR TRP PHE ARG THR ARG SER ALA ILE ILE
SEQRES 13 A 237 LEU HIS LEU SER ASN GLY SER VAL GLN ILE ASN PHE PHE
SEQRES 14 A 237 GLN ASP HIS THR LYS LEU ILE LEU CYS PRO LEU MET ALA
SEQRES 15 A 237 ALA VAL THR TYR ILE ASP GLU LYS ARG ASP PHE ARG THR
SEQRES 16 A 237 TYR ARG LEU SER LEU LEU GLU GLU TYR GLY CYS CYS LYS
SEQRES 17 A 237 GLU LEU ALA SER ARG LEU ARG TYR ALA ARG THR MET VAL
SEQRES 18 A 237 ASP LYS LEU LEU SER SER ARG SER ALA SER ASN ARG LEU
SEQRES 19 A 237 LYS ALA SER
SEQRES 1 C 7 ACE PRO LEU 2SO SER TPO NH2
MODRES 4O6W 2SO C 4 HIS
MODRES 4O6W TPO C 6 THR PHOSPHOTHREONINE
HET ACE C 1 3
HET 2SO C 4 25
HET TPO C 6 11
HET NH2 C 7 1
HETNAM ACE ACETYL GROUP
HETNAM 2SO 3-{3-[(3R)-3,4-DIHYDROXYBUTYL]-1-(8-PHENYLOCTYL)-1H-
HETNAM 2 2SO IMIDAZOL-3-IUM-5-YL}-L-ALANINE
HETNAM TPO PHOSPHOTHREONINE
HETNAM NH2 AMINO GROUP
HETSYN TPO PHOSPHONOTHREONINE
FORMUL 2 ACE C2 H4 O
FORMUL 2 2SO C24 H38 N3 O4 1+
FORMUL 2 TPO C4 H10 N O6 P
FORMUL 2 NH2 H2 N
FORMUL 3 HOH *218(H2 O)
HELIX 1 1 HIS A 373 SER A 387 1 15
HELIX 2 2 ARG A 396 GLU A 401 5 6
HELIX 3 3 ASP A 402 ILE A 406 5 5
HELIX 4 4 PRO A 469 SER A 471 5 3
HELIX 5 5 LEU A 472 HIS A 489 1 18
HELIX 6 6 LEU A 564 GLY A 571 1 8
HELIX 7 7 CYS A 573 SER A 593 1 21
SHEET 1 A 6 VAL A 411 ASP A 416 0
SHEET 2 A 6 GLY A 422 LEU A 427 -1 O GLY A 424 N VAL A 415
SHEET 3 A 6 VAL A 432 PHE A 436 -1 O GLY A 433 N TYR A 425
SHEET 4 A 6 ARG A 441 LEU A 444 -1 O LEU A 444 N VAL A 432
SHEET 5 A 6 SER A 450 ILE A 454 -1 O GLN A 452 N ILE A 443
SHEET 6 A 6 GLU A 460 THR A 464 -1 O SER A 461 N TYR A 453
SHEET 1 B 6 LEU A 511 ARG A 516 0
SHEET 2 B 6 ALA A 520 LEU A 525 -1 O ILE A 522 N PHE A 515
SHEET 3 B 6 VAL A 530 PHE A 534 -1 O GLN A 531 N LEU A 523
SHEET 4 B 6 LYS A 540 CYS A 544 -1 O LEU A 543 N VAL A 530
SHEET 5 B 6 ALA A 549 ILE A 553 -1 O ILE A 553 N LYS A 540
SHEET 6 B 6 PHE A 559 ARG A 563 -1 O TYR A 562 N VAL A 550
LINK C ACE C 1 N PRO C 2 1555 1555 1.35
LINK C LEU C 3 N 2SO C 4 1555 1555 1.34
LINK C 2SO C 4 N SER C 5 1555 1555 1.35
LINK C SER C 5 N TPO C 6 1555 1555 1.34
LINK C TPO C 6 N NH2 C 7 1555 1555 1.37
CRYST1 35.819 51.275 58.006 90.00 101.19 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.027918 0.000000 0.005521 0.00000
SCALE2 0.000000 0.019503 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017574 0.00000